Raymond J. Hohl

Biography

Dr. Hohl is a co-founder and the president of Terpenoid Therapeutics, and a member of the Board of Directors. He is a Professor of Internal Medicine and Pharmacology and the holder of the Holden Family Chair at the University of Iowa. He has clinical expertise and is board certified in Internal Medicine, Medical Oncology, Hematology, and Clinical Pharmacology. Dr. Hohl joined the University of Iowa in 1991 and from 1999 to 2005 he served as the Director of the Division of Hematology, Oncology and Blood & Marrow Transplantation. Since then he has been Associate Chair of the Department of Internal Medicine and Associate Director for Translational Research at the Holden Comprehensive Cancer Center. From 2003 through 2006 he served as a member of the Board of Directors for the American Society for Clinical Pharmacology and Therapeutics. He has received research support from the Roy J. Carver Charitable Trust, the National Institutes of Health, and the Leukemia & Lymphoma Society. At Iowa he directs a Carver Research Program of Excellence and the Roland W. Holden Family Program in Experimental Cancer Therapeutics. He is an Associate Editor for the Journal of Clinical Pharmacology and Therapeutics and a member of the editorial advisory board for the journal Lipids. Dr. Hohl received a BS in Biochemistry from the University of Illinois, an MD from Rush University, and a PhD in Pharmacology from Rush University.

Research Interest

 Biotechnology